[Alkylating tumor inhibitors--work mechenism and metabolism].
作者信息
Gescher A
出版信息
Pharm Unserer Zeit. 1976 Mar;5(2):41-52. doi: 10.1002/pauz.19760050202.
PMID:817296
Abstract
摘要
相似文献
1
[Alkylating tumor inhibitors--work mechenism and metabolism].
Pharm Unserer Zeit. 1976 Mar;5(2):41-52. doi: 10.1002/pauz.19760050202.
2
Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents.抗癌烷化剂的载体依赖型和非载体依赖型转运
Nature. 1981 Nov 19;294(5838):281-3. doi: 10.1038/294281a0.
3
[Specific histotropism of antineoplastic agents].
Clin Ter. 1970 Nov 30;55(4):293-303.
4
Novel 1-haloalkyl-2-nitroimidazole bioreductive alkylating agents.
Anticancer Drug Des. 1988 Mar;2(4):339-50.
5
Diaziridinylbenzoquinones.二氮丙啶基苯醌
Methods Enzymol. 2004;382:174-93. doi: 10.1016/S0076-6879(04)82010-X.
6
[Formation of precipitation areas in immunization with the alkylating compounds Lonin-3 and K-4].[使用烷基化化合物Lonin-3和K-4进行免疫时沉淀区域的形成]
Biull Eksp Biol Med. 1968 Mar;65(3):91-4.
7
COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
Cancer Chemother Rep. 1965 Jan;18:SUPPL 2:403+.
8
Cyclopropamitosenes: novel bioreductive anticancer agents--mechanism of action and enzymic reduction.环丙亚胺类：新型生物还原抗癌剂——作用机制与酶促还原
Anticancer Drugs. 1994 Jun;5(3):367-72.
9
COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
Cancer Chemother Rep. 1965 Jan;18:SUPPL 2:1-401.
10
Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).5-(3-甲基-1-三氮烯基)咪唑-4-甲酰胺（NSC-407347）的作用，它是一种由5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（NSC-45388）衍生而来的烷化剂。
Biochem Pharmacol. 1975 Mar 1;24(5):615-9. doi: 10.1016/0006-2952(75)90182-3.
Zotero 插件